Clinician Scientist. AI & Multi-omics. Biochemistry. Cancer Biology & Therapeutics @Harvard #PrecisionOncology #SpaceBiology @University_of_Malta
India
Joined December 2018
- Tweets1.1K
- Following535
- Followers485
- Likes8.1K
Anu R I retweeted
This is a global issue for both Cisplatin and carboplatin .. @ChandrakanthMv needs to be highlighted … affecting so many pts @AyushmanNHA @CancerGridIndia @cspramesh @ASCO @DrSanjayPopat @myESMO … not an expensive drug so industry not bothered. @PMOIndia @JPNadda @ICMRDELHI @jrgralow @drkiwicj
• Platinum chemotherapy shortage in India is becoming a major oncology challenge
• Cisplatin & carboplatin are backbone drugs across many cancers
• The issue is not just “drug availability” → raw material crisis → pricing pressure → manufacturing economics → supply-chain disruption
• Real-world impact: → treatment delays → dose modifications → regimen changes → inventory pressure
• Quick visual summary of: ✓ What is happening
✓ Why it is happening
✓ Clinical implications
✓ Possible solutions
Would like to hear how different centres are managing this situation.
#Oncology #CancerCare #DrugShortage #Cisplatin #Carboplatin #Chemotherapy #OncTwitter #MedTwitter #MVOnco
Anu R I retweeted
#TumorBoardTuesday
⌛️1y ago we learned of a major📈in the cure for early stage gastric cancer
📢Join us Tuesday, 05-12-26 at 8PM ET as @SunnieSKim & @aprilchoi_md 🗣️updates to the MATTERHORN trial & Tx for early stage #gastriccancer
RT and bring others into the discussion‼️
Anu R I retweeted
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
nature.com/articles/d41573-0…
Arvinas and Pfizer’s oestrogen receptor degrader vepdegestrant has secured approval for a subset of patients with advanced or metastatic breast cancer
